RenovoRx RNXT
NASDAQ RNXT
$1.22 +0.04 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST

RenovoRx (RNXT) Non-Current Deferred Tax Liability (2022 - 2024)

Updated

Analysis

RenovoRx (RNXT) Non-Current Deferred Tax Liability (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 RenovoRx 56.86 Mn 17.54 Mn 878,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -79,000.00
Dec 31, 2022 18,000.00
API Access

RenovoRx Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=RNXT&period=max&api_key=YOUR_API_KEY